PREDICTING SENSITIVITY OF BREAST TUMORS TO SRC-TARGETED THERAPIES THROUGH ASSESSMENT OF CAS/SRC/BCAR3 ACTIVITY

$1,096,871FY2015Department of the ArmyDOD

Rector & Visitors Of The University Of Virginia

Investigators